Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life-Reference-Cited by-同舟云学术

Anti-carcinoembryonic Antigen Single-chain Variable Fragment Antibody Variants Bind Mouse and Human Neonatal Fc Receptor with Different Affinities That Reveal Distinct Cross-species Differences in Serum Half-life

Published:2012-06 Issue:27 Volume:287 Page:22927-22937
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Andersen Jan Terje,Foss Stian,Kenanova Vania E.,Olafsen Tove,Leikfoss Ingvild S.,Roopenian Derry C.,Wu Anna M.,Sandlie Inger

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference57 articles.

1. Engineered antibody fragments and the rise of single domains;Holliger;Nat. Biotechnol.,2005

2. Tailoring antibodies for radionuclide delivery;Kenanova;Expert Opin. Drug Deliv.,2006

3. Arming antibodies. Prospects and challenges for immunoconjugates;Wu;Nat. Biotechnol.,2005

4. Increasing the serum persistence of an IgG fragment by random mutagenesis;Ghetie;Nat. Biotechnol.,1997

5. Quantitative methods for developing Fc mutants with extended half-lives;Kamei;Biotechnol. Bioeng.,2005

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A fusion protein of vimentin with Fc fragment inhibits Japanese encephalitis virus replication;Frontiers in Veterinary Science;2024-03-04

2. Chimerism of avian IgY‐scFv and truncated IgG‐Fc: A novel strategy in cross‐species antibody generation and enhancement;Immunology;2024-01-21

3. Antibody-mediated delivery of T-cell epitopes to antigen-presenting cells induce strong CD4 and CD8 T-cell responses;Vaccine;2021-03

4. SERS and electrochemical impedance spectroscopy immunoassay for carcinoembryonic antigen;Electrochimica Acta;2021-01

5. Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents;Antibodies;2020-12-15